**6. References**


Fungus as an Exacerbating Factor

6749

0001-5555

202X

6705

0022-1007

1529-2908

of Atopic Dermatitis, and Control of Fungi for the Remission of the Disease 151

Darabi, K., Hostetler, G., Bechtel, A. & Zirwas, M. (2009). The role of *Malassezia* in atopic

*of Dermatology*, Vol.60, No.1, (January 2009), pp.125-136, ISSN 0190-9622 Eberlein-Konig, B., Schafer, T., Huss-Marp, J., Darsow, U., Mohrenschlager, M., Herbert,

Eigenmann, A., Sicherer, H., Borkowski, A., Cohen, A. & Sampson, A. (1998). Prevalence

Elias, M. (2005). Stratum corneum defensive functions: an integrated view. *The Journal of* 

Elias, M. & Choi, H. (2005). Interactions among stratum corneum defensive functions.

Elias, M. (2007). The skin barrier as an innate immune element. *Seminars in Immunopathology*, Vol.29, No.1, (April 2007), pp.3-14, ISSN 1863-2297 Elias, M., Hatano, Y. & Williams, L. (2008). Basis for the barrier abnormality in atopic

Faergemann, J. (1999). *Pityrosporum* species as a cause of allergy and infection. *Allergy*,

Faergemann, J. (2002). Atopic dermatitis and fungi. *Clinical Microbiology Reviews*, Vol.15,

Farhadi, A., Banan, A., Fields, J. & Keshavarzian A. (2003). Intestinal barrier: an interface

Fiorentino, F., Bond, W. & Mosmann, R. (1989). Two types of mouse T helper cell. IV. Th2

Galli, J., Nakae, S. & Tsai, M. (2005). Mast cells in the development of adaptive immune

Gupta, K., Batra, R., Bluhm, R., Boekhout, T. & Dawson, L, Jr. (2004). Skin diseases

Gupta, K., Kohli, Y., Summerbell, C., & Faergemann, J. (2001). Quantitative culture of

Vol.51, No.5, (November 2004), pp.785-98, ISSN 0190-9622

Vol.101, No.3, (March 1998), p.E8, ISSN 0031-4005

Vol.54, No.5, (May 1999), pp.413–419, ISSN 1398-9995

No.4, (October 2002), pp.545-563, ISSN 0893-8512

No.5, (May 2003), pp.479-497, ISSN 0815-9319

*Allergy and Clinical Immunology*, Vol.118, No.1, (July 2006), pp.3-21, ISSN 0091-

dermatitis affecting the head and neck of adults. *Journal of the American Academy* 

O., Abeck, D., Kramer, U., Behrendt, H. & Ring, J. (2000). Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. *Acta Dermato-Venereologica*, Vol.80, No.3, (May 2000), pp.188-191, ISSN

of IgE-mediated food allergy among children with atopic dermatitis. *Pediatrics*,

*Investigative Dermatology*, Vol.125, No.2, (August 2005), pp.183-200, ISSN 0022-

*Experimental Dermatology*, Vol.14, No.10, (October 2005), pp.719-726, ISSN 0906-

dermatitis: outside-inside-outside pathogenic mechanisms. *The Journal of Allergy and Clinical Immunology*, Vol.121, No.6, (June 2006), pp.1337-1343, ISSN 0091-6749

between health and disease. *Journal of Gastroenterology and Hepatology*, Vol.18,

clones secrete a factor that inhibits cytokine production by Th1 clones. *The Journal of Experimental Medicine*, Vol.170, No.6, (December 1989), pp.2081-2095, ISSN

responses. *Nature Immunology*, Vol.6, No.2, (February 2005), pp.135-142, ISSN

associated with *Malassezia* species. *Journal of the American Academy of Dermatology*,

*Malassezia* species from different body sites of individuals with or without


Bond, R., Curtis, F., Ferguson, A., Mason, S. & Rest, J. (2000). An idiopathic facial

Boom, H., Liano, D. & Abbas, K. (1998). Heterogeneity of helper/inducer T lymphocytes.

Brehler, S., & Luger, T. (2001). Atopic dermatitis: the role of *Pityrosporum ovale*. *Journal of* 

Broberg, A., Faergemann, J., Johansson, S., Johansson, S. & Strannegard, I. (1992).

*Venereologica*, Vol.75, No.1, (January 1995), pp.46–49, ISSN 0001-5555 Brown, J. & McLean, H. (2009). Eczema genetics: current state of knowledge and future

Bunikowski, R., Mielke, M., Skarabis, H., Herz, U., Bergmann, L., Wahn, U. & Renz, H.

Buslau, M., Menzel, I. & Holzmann, H. (1990). Fungal flora of human feces in psoriasis

Chamlin, L., Kao, J., Frieden, J., Sheu, Y., Fowler, J., Fluhr, W., Williams, L. & Elias, M.

Chen, A., Halliwell, E., Pemberton, D. & Hill, B. (2002). Identification of major allergens of

Cork, J., Danby, G., Vasilopoulos, Y., Hadgraft, J., Lane, E., Moustafa, M., Guy, H.,

Cork, J., Robinson, A., Vasilopoulos, Y., Ferguson, A., Moustafa, M., MacGowan, A., Duff,

pp.35-41, ISSN 0959-4493

pp.1350-1363, ISSN 0022-1007

PP.5–6, ISSN 0926-9959

552, ISSN 0022-202X

0091-6749

0959-4493

ISSN: 1439-0507

2002), pp.198-208, ISSN 0190-9622

(August 2009), 1892-1908, ISSN 0022-202X

dermatitis of Persian cats. *Veterinary Dermatolog,* Vol.11, No.1, (March 2000),

II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes. *The Journal of Experimental Medicine*, Vol.167, No.4, (April 1998),

*the European Academy of Dermatology and Venereology*, Vol.15, No.1, (January 2001),

*Pityrosporum ovale* and atopic dermatitis in children and young adults. *Acta Dermato-Venereologica*, Vol.72, No.3, (March 1992), pp.187–192, ISSN 0001-5555 Broberg, A. & Faergemann, J. (1995). Topical antimycotic treatment of atopic dermatitis in

the head/neck area. A double-blind randomized study. *Acta Dermato-*

goals. *The Journal of Investigative Dermatology*, Vol.129, No.3, (March 2009), pp.543-

(1999). Prevalence and role of serum IgE antibodies to the *Staphylococcus aureus*derived superantigens SEA and SEB in children with atopic dermatitis. *Journal of Allergy and Clinical Immunology*, Vol.103, No.1, (January 1999), pp.119–124, ISSN

and atopic dermatitis. *Mycoses*, Vol.33, No.2, (February 1990), pp.90-94,

(2002). Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. *Journal of the American Academy of Dermatology*, Vol.47, No.2, (August

*Malassezia pachydermatis* in dogs with atopic dermatitis and *Malassezia* overgrowth. *Veterinary Dermatology*, Vol.13, No.3, (June 2002), pp.141-150, ISSN

Macgowan, L., Tazi-Ahnini, R. & Ward, J. (2009). Epidermal barrier dysfunction in atopic dermatitis. *The Journal of Investigative Dermatology*, Vol.129, No.8,

W., Ward, J. & Tazi-Ahnini R. (2006). New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. *The Journal of*  *Allergy and Clinical Immunology*, Vol.118, No.1, (July 2006), pp.3-21, ISSN 0091- 6749


Fungus as an Exacerbating Factor

of Atopic Dermatitis, and Control of Fungi for the Remission of the Disease 153

Katsarou, A. & Armenaka, M. (2011). Atopic dermatitis in older patients: particular

Killar, L., MacDonald, G., West, J., Woods, A. & Bottomly, K. (1987). Cloned, Ia-restricted

Kitamura, K., Suga, C., Onuma, S., Kawaguchi, T., Yamazaki, F., Suguro, H. & Ikezawa, Z.

Klein, A., Clark, A. & Nicol, H. (1999). Acute infection with *Trichophyton rubrum*

Lacour M, Zunder T, Huber R, Sander A, Daschner F, Frank U. (2002). The pathogenetic

Lever, R., MacDonald, C., Waugh, P. & Aitchison, T. (1998). Randomised controlled trial

Linder, M., Johansson, C., Scheynius, A. & Wahlgren, C. (2000). Positive atopy patch test

Majamaa, H. & Isolauri, E. (1996). Evaluation of the gut mucosal barrier: evidence for

McFadden, P., Noble, C. & Camp, R. (1993). Superantigenic exotoxin secreting potential of

Morita, E., Hide, M., Yoneya, Y., Kannbe, M., Tanaka, A. & Yamamoto S. (1999). An

*of dermatology*, Vol.26, No.5, (May 1999), pp.282-287, ISSN 0385-2407

No.1, (January 2011), pp.12-18, ISSN 0926-9959

(March 1987), pp.1674-1679, ISSN 0022-1767

pp.171-172, ISSN 0011-4162

pp.13-19, ISSN 0905-6157

No.3, (June 2006), pp.153-158, ISSN 1660-5527

No.10, (October 2004), pp.787-799, ISSN 1474-1733

Vol.128, No.6, (January 1993), pp.631–632, ISSN 0007-0963

1438-4639

Vol.46, No.2, (June 1997), pp.125-133, ISSN 1323-8930

points. *Journal of the European Academy of Dermatology and Venereology*, Vol.25,

T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. *The Journal of Immunology*, Vol.138, No.6,

(1997). Efficacy of oral amphotericin B for refractory atopic dermatitis with specific IgE to *Candida albicans* and food allergens in sera. *Allergology International*,

associated with flares of atopic dermatitis. *Cutis*, Vol.63, No.3, (March 1999),

significance of intestinal *Candida* colonization--a systematic review from an interdisciplinary and environmental medical point of view. *International Journal of Hygiene and Environmental Health*, Vol.205, No.4, (May 2002), pp.257-268, ISSN

of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. *Pediatric Allergy and Immunology*, Vol.9, No.1, (February 1998),

reactions to *Pityrosporum orbiculare* in atopic dermatitis patients. *Clinical and Experimental Allergy*, Vol.30, No.1, (January 2000), pp.122-131, ISSN 0954-7894 Lintu, P., Savolainen, J. & Kalimo, K. (1997). IgE antibodies tp protein and mannan

antigens of *Pityrosporum ovale* in atopic dermatitis patients. *Clinical and Experimental Allergy*, Vol.27, No.1, (January 1997), pp.87–95, ISSN 0954-7894 Mayser, P., Kupfer, J., Nemetz, D., Schäfer, U., Nilles, M., Hort, W. & Gieler, U. (2006).

Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study. *Skin Pharmacology and Physiology*, Vol.19,

increased antigen transfer in children with atopic eczema. *The Journal of allergy and clinical immunology*, Vol.97, No.4, (April 1996), pp.985-990, ISSN 0091-6749 Marshall, S. (2004). Mast-cell responses to pathogens. *Nature Reviews Immunology*, Vol.4,

staphylococci isolated from atopic eczematous skin. *British Journal of Dermatology*,

assessment of the role of *Candida albicans* antigen in atopic dermatitis. *The Journal* 

dermatoses. *Medical mycology*, Vol.39, No.3, (Jun 2001), pp.243-251, ISSN 1369- 3786


Henz, M., Maurer, M., Lippert, U., Worm, M. & Babina, M. (2001). Mast cells as initiators

Herz, U., Bunikowski, R., Mielke, M. & Renz, H. (1999). Contribution of bacterial

*Microbiology*. Vol.54, No.2, (March 2004), pp.623-627, ISSN 1466-5026 Huang, X., Johansson, G., Zargari, A. & Nordvall, L. (1995). Allergen cross-reactivity

Hudson, J. (2006). Skin barrier function and allergic risk. *Nature Genetics*, Vol.38, No.4,

Jackson, G., Lessof, H., Baker, W., Ferrett, J. & MacDonald, M. (1981). Intestinal

Jazic, E., Coyner, S., Loeffler, G. & Lewis, P. (2006). An evaluation of the clinical,

Jin, J.H., Ngoc, T.M., Bae K, Kim, Y.S., & Kim, H.P. (2011). Inhibition of experimental

Kaga, M., Sugita, T., Nishikawa, A., Wada, Y., Hiruma, M. & Ikeda, S. (2009). Molecular

Kanda, N., Tani, K., Enomoto, U., Nakai, K. & Watanabe, S. (2002). The skin fungus-

Kato, H., Sugita, T., Ishibashi, Y. & Nishikawa, A. (2006). Detection and quantification of

*Dermatology*, Vol.17, No.2, (April 2006), pp.134-140, ISSN 0959-4493 Jensen-Jarolim, E., Poulsen, K., With, H., Kieffer, M., Ottevanger, V., Stahl Skov, P. (1992).

3786

2001), pp.1-10, ISSN 0906-6705

(August 1995), pp.648–656, ISSN 1398-9995

(April 2006), pp.399-400, ISSN, 1061-4036

(June 1981), pp.1285-1286, ISSN 0140-6736

(January 1992), pp.44–50, ISSN 0091-6749

(May 2011), pp.755-759, ISSN 0951-418X

(August 2002), pp.1243-1250, ISSN 0954-7894

December 2009, ISSN: 1439-0507

dermatoses. *Medical mycology*, Vol.39, No.3, (Jun 2001), pp.243-251, ISSN 1369-

of immunity and host defense. *Experimental Dermatology*, Vol.10, No.1, (February

superantigens to stopic dermatitis. *International Archives of Allergy and Immunology*, Vol.118, No.2-4, (February-April 1999), pp.240–241, ISSN 1018-2438 Hirai, A., Kano, R., Makimura, K., Duarte, R., Hamdan, S., Lachance, A., Yamaguchi, H. &

Hasegawa, A. (2004). *Malassezia* nana sp. nov., a novel lipid-dependent yeast species isolated from animals. *International Journal of Systematic and Evolutionary* 

between *Pityrosporum orbiculare* and *Candida albicans*. *Allergy*, Vol.50, No.8,

permeability in patients with eczema and food allergy. *Lancet*, Vol.317, No.8233,

cytological, infectious and histopathological features of feline acne. *Veterinary* 

Atopic dermatitis of the face, scalp and neck: type I reaction to the yeast *Pityrosporum ovale*? *The Journal of Allergy and Clinical Immunology*, Vol.89, No.1,

atopic dermatitis by rhubarb (rhizomes of *Rheum tanguticum*) and 5-lipoxygenase inhibition of its major constituent, emodin. *Phytotherpy Research*, Vol.25, No.5,

analysis of the cutaneous *Malassezia microbiota* from the skin of patients with atopic dermatitis of different severities. *Mycoses*. Article first published online: 11

induced Th1- and Th2-related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris. *Clinical and Experimental Allergy*, Vol.32, No.8,

specific IgE antibodies against eight *Malassezia* species in sera of patients with atopic dermatitis by using an enzyme-linked immunosorbent assay. *Microbiology and Immunology*, Vol.50, No.11, (November 2006), pp.851-856, ISSN 1348-0421


Fungus as an Exacerbating Factor

2007), pp.1261-1263. ISSN: 0022-202X

2006), pp.610-618, ISSN 0006-4971

pp.332–339, ISSN 0954-7894

134, ISSN 0954-7894

4036

of Atopic Dermatitis, and Control of Fungi for the Remission of the Disease 155

Peng, M., Jenneck, C., Bussmann, C., Bogdanow, M., Hart, J., Leung, Y., Bieber, T., Eis-

Pike, G., Heddle, J., Boulton, P., Turner, W. & Atherton, J. (1986). Increased intestinal

Proksch, E., Folster-Holst, R. & Jensen, M. (2006). Skin barrier function, epidermal

Qiao, H., Andrade, V., Lisboa, A., Morgan, K. & Beaven, A. FcepsilonR1 and toll-like

Rokugo, M., Tagami, H., Usuba, Y. & Tomota, Y. (1990). Contact sensitivity to

Romani, L., Cenci, E., Menacci, A., Bistoni, F. & Puccetti, P. (1995). T helper cell dichotomy

1986;Vol.86, No.2, (February 1986), pp.101-104, ISSN 0022-202X

2006;Vol.43, No.3, (September 2006), pp.159-169, ISSN 0923-1811

Vol.126, No.5, (May 1990), pp.627–632, ISSN 0003-987X

Sergeant, A., Munro, S., El Houate, B., McElreavey, K., Halkjaer, B., Bisgaard, H., Mukhopadhyay, S. & McLean, H. (2006). Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. *Nature Genetics*, Vol.38, No.4, (April 2006), pp.441-446, ISSN 1061-

Hübinger, M. & Novak, N. (2007). Risk factors of atopic dermatitis patients for eczema herpeticum. *Journal of Investigative Dermatology*, Vol.127, No.5, (May

permeability in atopic eczema. *The Journal of Investigative Dermatology*,

proliferation and differentiation in eczema. *Journal of Dermatological Science*,

receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. *Blood* 2006;Vol.107, No.2, (January

*Pityrosporum ovale* in patients with atopic dermatitis. *Archives of Dermatology*,

to *Candida albicans*: implications for pathology, therapy, and vaccine design. *Immunologic Research*, Vol.14, No.2, (June 1995), pp.148-162, ISSN 0257-277X Sandström, H., Tengvall, M., Johansson, C., Bartosik, J., Bäck, O., Särnhult, T., Wahlgren,

F., Scheynius, A. & Faergemann, J. (2005). The prevalence of *Malassezia* yeasts in patients with atopic dermatitis, seborrheic dermatitis and healthy controls. *Acta Dermato-Venereologica*, Vol.85, No.1, (January 2005), pp.17-23, ISSN 0001-5555 Savolainen, J. Lammintausta, K., Kalimo, K. & Viander, M. (1993). *Candida albicans* and

atopic dermatitis. *Clinical and Experimental Allergy*, Vol.23, No.4, (April 1993),

Kalimo, K., Terho, E. & Bousquet, J. (2001). *Pityrosporum* and *Candida* specific and non-specific humoral, cellular and cytokine responses in atopic dermatitis patients. *Clinical and Experimental Allergy*, Vol.31, No.1, (January 2001), pp.125–

(1999). Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. *The Journal of Allergy and Clinical Immunology*, Vol.104, No.6,

Härfast, B. & Scheynius, A. (1997). The complete cDNA sequence and expression

Savolainen, J., Lintu, P., Kosonen, J., Kortekangas-Savolainen, O., Viander, M., Pene, J.,

Scalabrin, M., Bavbek, S., Perzanowski, S., Wilson, B., Platts-Mills, A. & Wheatley, M.

Schmidt, M., Zargari, A., Holt, P., Lindbom, L., Hellman, U., Whitley, P., van der Ploeg, I.,

(December 1999), pp.1273-1279, ISSN 0091-6749


Morris, O., Clayton, J., Drobatz, J. & Felsburg, J. (2002). Response to *Malassezia* 

Mosmann, R., Cherwinski, H., Bond, W., Giedlin, A. & Coffman, L. (1986). Two types of

Mukai, H., Kaneko, S., Saito, N., Nagase, A., Arai, S. & Hiramatsu M. (1997). Clinical

Nakabayashi, A., Sei, Y. & Guillot, J. (2000). Identification of *Malassezia* species isolated

Niebuhr, M., Gathmann, M., Scharonow, H., Mamerow, D., Mommert, S., Balaji, H. &

Nikkels, F. & Pierard, E. (2003). Framing the future of antifungals in atopic dermatitis. *Dermatology*, Vol.206, No.4, (June 2003), pp.398-400, ISSN 1018-8665 Nikkels, F. & Pierard, E. (2003). Framing the future of antifungals in atopic dermatitis. *Dermatology*, Vol.206, No.4, (May 2003), pp.398-400, ISSN 1018-8665 Ogawa, H. & Yoshiike, T. (1993) A speculative view of atopic dermatitis: barrier

Ong, Y. & Leung, Y. (2010). The infectious aspects of atopic dermatitis. *Immunology and*

Ordeix, L., Galeotti, F., Scarampella, F., Dedola, C., Bardagi, M., Romano, E. & Fondati, A.

O'Regan, M., Sandilands, A., McLean, H. & Irvine, D. (2009). Filaggrin in atopic

Orita, K., Hiramoto, K., Inoue, R., Sato, E.F., Kobayashi, H., Ishii, M., & Inoue, M. (2010).

Palmer, N., Irvine, D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, P., Goudie, R.,

*Arerugi*, Vo.46, No.1, (January 1997), pp.26-33, ISSN 0021-4884

pp.358-362, ISSN 0002-9645

ISSN:1369-3786

1098-5522

8561

1987), pp.2348-2357, ISSN 0022-1767

National Center for Biotechnology Information,

1993), pp.197-204, ISSN 0923-1811

No.5, (October 2007), pp.316-323, ISSN 0959-4493

(December 2010), pp.1067- 1072, ISSN 0906-6705

Supplement 2, (September 2009), pp.R2-6, ISSN 0091-6749

http://www.ncbi.nlm.nih.gov/taxonomy, May, 2011.

*pachydermatis* by peripheral blood mononuclear cells from clinically normal and atopic dogs. *American Journal of Veterinary Research*, Vol.63, No.3, (March 2002),

murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. *The Journal of Immunology*, Vol.136, No.7, (April

significance of *Malassezia furfur* specific IgE antibody in atopic dermatitis.

from patients with seborrheic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. *Medical Mycology*, Vol.38, No.5, (May 2000), pp.337-341,

Werfel, T. (2011). Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. *Infection and Immunity*, Vol.79, No.4, (April 2011), pp.1615-1622, ISSN

dysfunction in pathogenesis. *Journal of Dermatological Science*, Vol.5, No.3, (June

*Allergy Clinics of North America*, Vol.30, No.3, (August 2010), pp.309-321, 0889-

(2007). *Malassezia* spp. overgrowth in allergic cats. *Veterinary Dermatology*, Vol.18,

dermatitis. *The Journal of Allergy and Clinical Immunology*, Vol.124, No.3,

Strong exercise stress exacerbates dermatitis in atopic model mice, NC/Nga mice, while proper exercise reduces it. *Experimental Dermatology*, Vol.19, No.12,

Sandilands, A., Campbell, E., Smith, J., O'Regan, M., Watson, M., Cecil, E., Bale, J., Compton, G., DiGiovanna, J., Fleckman, P., Lewis-Jones, S., Arseculeratne, G., Sergeant, A., Munro, S., El Houate, B., McElreavey, K., Halkjaer, B., Bisgaard, H., Mukhopadhyay, S. & McLean, H. (2006). Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. *Nature Genetics*, Vol.38, No.4, (April 2006), pp.441-446, ISSN 1061- 4036


Fungus as an Exacerbating Factor

3997

987X

2008), pp.345-351, ISSN 0022-202X

of Atopic Dermatitis, and Control of Fungi for the Remission of the Disease 157

Tajima, M., Sugita, T., Nishikawa, A. & Tsuboi, R. (2008). Molecular analysis of *Malassezia*

Takagi, T., Naito, Y., Inoue, M., Akagiri, S., Mizushima, K., Handa, O., Kokura, S.,

Tanaka, M., Aiba, S., Matsumura, N., Aoyama, H., Tabata, N., Sekita, Y. & Tagami, H.

Tupker, A., Pinnagoda, J., Coenraads, J. & Nater, P. (1990). Susceptibility to irritants: role

Watanabe, M., Tagami, H., Horii, I., Takahashi, M. & Kligman, M. (1991). Functional

Williams, C. (2000). Epidemiology of atopic dermatitis. *Clinical and Experimental Dermatology*, Vol.25, No.7, (October 2000), pp. 522–529. ISSN 0307-6938 Williams, C., & Wüthrich, B. (2000). The natural history of atopic dermatitis, In Atopic

Wollenberg, A., Wetzel, S., Burgdorf, H. & Haas, J. (2003). Viral infections in atopic

Yeung, M., Balma-Mena, A., Shear, N., Simor, A., Pope, E., Walsh, S. & McGavin, J. (2011).

No.11, (November 1994), pp.1393-1401, ISSN 0365-6020

Part1, (February 1998), 207-209, ISSN 0091-6749

57075-1, Cambridge, United Kingdom.

Vol.55, No.7, (July 2006), pp.954-960, ISSN 0017-5749

Vol.13, No.2, (February 2011), pp.189-197, ISSN 1286-4579

and 400 mg daily for 1 week with placebo. *Journal of the European Academy of Dermatology and Venereology*, Vol.18, No.4, (July 2004), pp.445-449, ISSN 0926-9959

microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. *The Journal of Investigative Dermatology*, Vol.128, No.2, (February

Ichikawa, H. & Yoshikawa, T. (2009). Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1. *Inflammation*, Vol.32, No.2, (April 2009), pp.83-88, ISSN 0360-

(1994). IgE-mediated hypersensitivity and contact sensitivity to multiple environmental allergens in atopic dermatitis. *Archives of Dermatology*, Vol.130,

of barrier function, skin dryness and history of atopic dermatitis. *The British Journal of Dermatology*, Vol.123, No.2, (August 1990), pp.199-205, ISSN 0007-0963 Turner, H. & Kinet, P. (1999). Signalling through the high-affinity IgE receptor Fc epsilonRI. *Nature*, 1999;Vol.402, No.6760, Supplement :B24-30, ISSN: 0028-0836 van Reijsen, C., Felius, A., Wauters, A., Bruijnzeel-Koomen, A. & Koppelman, J. (1998). T-

cell reactivity for a peanut-derived epitope in the skin of a young infant with atopic dermatitis. *The Journal of Allergy and Clinical Immunology*, Vol.101, No.2,

analyses of the superficial stratum corneum in atopic xerosis. *Archives of Dermatology*, 1991;Vol.127, No.11, (November 1991), pp.1689-1692, ISSN 0003-

dermatitis, H.C. Williams (Ed.), 41–59, Cambridge University Press, ISBN 0-521-

dermatitis: pathogenic aspects and clinical management. *Journal of Allergy and Clinical Immunology*, Vol.112, No.4, (October 2003), pp.667-674, ISSN 0091-6749 Yamaguchi, N., Sugita, R., Miki, A., Takemura, N., Kawabata, J., Watanabe, J. &

Sonoyama, K. (2006). Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice. *Gut*,

Identification of major clonal complexes and toxin producing strains among *Staphylococcus aureus* associated with atopic dermatitis. *Microbes and Infection*,

of the first major allergenic protein of *Malassezia furfur*, Mal f 1. *European Journal of Biochemistry*, Vol.246, No.1, (May 1997), pp.181–185, ISSN 0014-2956


*of Biochemistry*, Vol.246, No.1, (May 1997), pp.181–185, ISSN 0014-2956 Seidenari, S. & Giusti, G. (1995). Objective assessment of the skin of children affected by

Selander, C., Engblom, C., Nilsson, G., Scheynius, A. & Andersson, L. TLR2/MyD88-

Setoguchi, C., Tsuji, F., Katsuta, O., Okamoto, M. & Aono, H. (2010). Combined effects of

Sonoyama, K., Miki, A., Sugita, R., Goto, H., Nakata, M. & Yamaguchi, N. (2011). Gut

Stout, D. & Bottomly, K. (1989). Antigen-specific activation of effector macrophages by

Sugarman, L., Fluhr, W., Fowler, J., Bruckner, T., Diepgen, L. & Williams, L. (2003). The

Sugita, T., Suto, H., Unno, T., Tsuboi, R., Ogawa, H., Shinoda, T. & Nishikawa, A. (2001).

Sugita, T., Tajima, M., Amaya, M., Tsuboi, R. & Nishikawa, A. (2004). Genotype analysis

Sugita, T., Tajima, M., Tsubuku, H., Tsuboi, R. & Nishikawa, A. (2006). Quantitative

Svejgaard, E., Larsen, Ø., Deleuran, M., Ternowitz, T., Roed-Petersen, J. & Nilsson, J.

Vol.142, No.3, (February 1989), pp.760-765, ISSN 0022-1767

Vol.139, No.11, (November 2003), pp.1417-1422, ISSN 0003-987X

(October 2001), pp.3486-3490, ISSN 0095-1137

(October 2004), 755-759, ISSN 1348-0421

ISSN 1348-0421

1995), pp.429-433, ISSN 0001-5555

1369-3786

(April 2009), pp.4208-4216, ISSN 0022-1767

No.2, (February 2000), pp.158-161, ISSN 0002-9645

of the first major allergenic protein of *Malassezia furfur*, Mal f 1. *European Journal* 

atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. *Acta Dermato-Venereologica*, Vol.75, No.6, (November

dependent and -independent activation of mast cell IgE responses by the skin commensal yeast *Malassezia sympodialis*. *The Journal of Immunology*, Vol.182, No.7,

bucillamine and etanercept on a rat type II collagen-induced arthritis model. *Modern Rheumatology,* Vol.20, No.4, (August 2010), pp.381-388, ISSN 1439-7595 Sierra, P., Guillot, J., Jacob, H., Bussieras, S. & Chermette, R. (2000). Fungal flora on

cutaneous and mucosal surfaces of cats infected with feline immunodeficiency virus or feline leukemia virus. *American Journal of Veterinary Research*, Vol.61,

colonization by *Candida albicans* aggravates inflammation in the gut and extra-gut tissues in mice. *Medical Mycology*, Vol.49, No.3, (April 2011), pp.237-247, ISSN

IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. *The Journal of Immunology*,

objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. *Archives of Dermatology*,

Molecular analysis of *Malassezia* microflora on the skin of atopic dermatitis patients and healthy subjects. *Journal of Clinical Microbiology*, Vol.39, No.10,

of *Malassezia restricta* as the major cutaneous flora in patients with atopic dermatitis and healthy subjects. *Microbiology and Immunology*, Vol.48, No.10,

analysis of cutaneous *Malassezia* in atopic dermatitis patients using real-time PCR. *Microbiology and Immunology*, Vol.50, No.7, (July 2006), pp.549-552,

(2004). Treatment of head and neck dermatitis comparing itraconazole 200 mg

and 400 mg daily for 1 week with placebo. *Journal of the European Academy of Dermatology and Venereology*, Vol.18, No.4, (July 2004), pp.445-449, ISSN 0926-9959


**Part 3** 

**Diagnosis and Clinical Management** 

Yim, M., Kim, Y., Ko, H., Lee, W., Choe, B. & Ahn, J. (2010). Molecular analysis of *Malassezia* microflora on the skin of the patients with atopic dermatitis. *Annals of Dermatology*, Vol.22, No.1, (February 2010), pp.41-47, ISSN 1013-9087
